ライフサイエンスコーパス: fistula

1 lusion criteria (61 unique cohorts; n>11,374 fistulas).

2 venous hypertensive events (1 cohort; n=350 fistulas).

3 and clinical remission (absence of draining fistulas).

4 lied in a bioabsorbable matrix, can heal the fistula.

5 noeuvers used to demonstrate the size of the fistula.

6 ed for surgical/endoscopic repair of the CSF fistula.

7 flow, an indirect sign of carotid cavernous fistula.

8 clinically relevant postoperative pancreatic fistula.

9 of the gall bladder and cholecysto-cutaneous fistula.

10 tinal fluid secondary to a carotid cavernous fistula.

11 as a rare complication of carotid cavernous fistula.

12 tive modality for the evaluation of perianal fistula.

13 nt of which are the size and location of the fistula.

14 essels, or had a previous failed ipsilateral fistula.

15 istula repair breakdown in women with simple fistula.

16 ng right T7 to T8 spinal dural arteriovenous fistula.

17 s the salvage of a functioning arteriovenous fistula.

18 and IV are associated with post-palatoplasty fistula.

19 they were pregnant; or if they had multiple fistula.

20 ortality benefit observed in patients with a fistula.

21 y of his abdominal vessels and arteriovenous fistula.

22 women who presently have symptoms of vaginal fistula.

23 occurrence of clinically relevant pancreatic fistula.

24 re (grade 2), and 1 (2%) a grade 4 bronchial fistula.

25 n patients with Crohn's disease and perianal fistulas.

26 d and underwent 154 PTAs in 56 grafts and 98 fistulas.

27 ary patency was 34.8% in grafts and 47.1% in fistulas.

28 MSCs appeared to promote healing of perianal fistulas.

29 (36% vs 63%) and no postoperative pancreatic fistulas.

30 ition of healthy tissue in radiation-induced fistulas.

31 s with prospectively captured data on >/=100 fistulas.

32 tment-refractory, draining, complex perianal fistulas.

33 nderutilized technique for defining perianal fistulas.

34 6%), cleft lip or palate (0%), and obstetric fistula (0%).

35 stulas), 0.11 infections (16 cohorts; n>6439 fistulas), 0.05 steal events (15 cohorts; n>2543 fistula

36 s: 0.04 aneurysms (14 unique cohorts; n=1827 fistulas), 0.11 infections (16 cohorts; n>6439 fistulas)

37 ulas), 0.05 steal events (15 cohorts; n>2543 fistulas), 0.24 thrombotic events (26 cohorts; n=4232 fi

38 oped acute complications (pleuro-pericardial fistula 1 and pericardial bleeding 1).

39 wever, they had significantly lower rates of fistula (15 [39.5%] vs 35 [92.1%] of 38; P < .001).

40 clinically relevant postoperative pancreatic fistula (18% vs 12%, P = 0.11) or mortality (0% vs 1%, P

41 [21%] vs 19 [15%], P = 0.24) and pancreatic fistulas (20 [28%] vs 41 [32%], P = 0.62) were not signi

42 orse surgical results with higher pancreatic fistula (21.1% vs 14.6%; P < 0.01) and mortality rates (

43 (1.99-4.97)], sepsis [1.88 (1.29-2.73)], and fistula [3.50 (2.17-5.66)].

44 Grade 4 was the most common type of fistula (34%) while Grade 5 was the least common type (4

45 regionalization trends for tracheoesophageal fistula (66% to 87%, P < 0.001) and gastroschisis (76% t

46 had a chronic complication indication (15.6% fistula, 7.4% stricture, 3.0% bleeding, 5.8% other).

47 ents of fistulas, and discusses the types of fistulas according to the standard Parks classification.

48 ed with the development of atrial-esophageal fistula (AEF) and increased mortality.

49 The development of atrioesophageal fistula (AEF) is among the most serious and lethal compl

50 001], respectively), incidence of pancreatic fistula after 40 cases (27.5% vs 14.4%; P = .04), and op

51 as first intervention for severe pancreatic fistula after pancreatoduodenectomy was associated with

52 parotomy as primary treatment for pancreatic fistula after pancreatoduodenectomy.

53 nificant difference in the rate of grade B/C fistula after PG versus PJ (20% vs 22%, P = 0.617).

54 The rate of grade B/C fistula after PG versus PJ was not different.

55 e relative risks of mortality and pancreatic fistula after these procedures.

56 t treatment modalities are selected based on fistula anatomy, patient factors, and management goals (

57 Two patients (1 atrioesophageal fistula and 1 esophagopericardial fistula) died.

58 INTERPRETATION: Recurrence of female genital fistula and adverse pregnancy-related maternal and child

59 clinically relevant postoperative pancreatic fistula and wound infection, length of stay, or 90-day r

60 Patients with enteric fistulas and an abdominal wall defect present an extreme

61 ition, the MR appearance of healing perianal fistulas and fistula complications is described.

62 sks including the assessment of rectovaginal fistulas and ileoanal anastomoses are highlighted, along

63 , 0.24 thrombotic events (26 cohorts; n=4232 fistulas), and 0.03 venous hypertensive events (1 cohort

64 first, 9794 initiated hemodialysis with that fistula, and 8230 initiated dialysis with a catheter aft

65 a-in-ano, demonstrates various components of fistulas, and discusses the types of fistulas according

66 clusion criteria were an active infection or fistula, antibiotic treatment, reimplantation of osteosy

67 Fistula (any grade) occurred in 32 (15%) of 220 patients

68 Esophageal ulceration and fistula are complications of pulmonary vein isolation us

69 Perianal fistulas are a leading cause of patient morbidity becaus

70 Carotid-cavernous fistulas are abnormal communications between the carotid

71 o cells, n = 6), into the wall of curettaged fistula, around the trimmed and closed internal opening.

72 escribe a case of an infected atriobronchial fistula as a late complication after pulmonary vein abla

73 advanced medical care, cholecysto-cutaneous fistula as a potential diagnosis should be kept in mind

74 venous malformations and dural arteriovenous fistulas, ASL is very sensitive to detect even small deg

75 Since these are high-flow fistulas, assessment requires certain manoeuvers.

76 : drain 11.9%, no-drain 5.7%; P = 0.030) and fistula-associated complications (drain 26.4%; no drain

77 nically relevant pancreatic fistula rate and fistula-associated complications.

78 attempt than in those without a predialysis fistula attempt in patients aged <65 years (hazard ratio

79 In conclusion, predialysis fistula attempt may associate with a lower risk of morta

80 Overall, the advantages of an AV fistula attempt strategy lessened considerably among old

81 An AV fistula attempt strategy was found to be superior to AV

82 y in individuals who underwent a predialysis fistula attempt than in those without a predialysis fist

83 performed a decision analysis evaluating AV fistula, AV graft, and central venous catheter (CVC) str

84 Arteriovenous fistula (AVF) access improves survival in patients with

85 established with the use of an arteriovenous fistula (AVF) at first hemodialysis.

86 ped around the outflow vein of arteriovenous fistula (AVF) at the time of creation could reduce VNH.

87 Arteriovenous fistula (AVF) is the preferred vascular access for hemod

88 Arteriovenous fistula (AVF) maturation failure is the primary cause of

89 ng risk of death, high rate of arteriovenous fistula (AVF) maturation failure, and poor vascular acce

90 Low rates of arteriovenous fistula (AVF) maturation prevent optimal fistula use for

91 itiating hemodialysis (HD) via arteriovenous fistula (AVF) or arteriovenous graft (AVG) vs hemodialys

92 tly undergo placement of a new arteriovenous fistula (AVF) or arteriovenous graft (AVG).

93 st one cerebral or spinal pial arteriovenous fistula (AVF), and to describe their clinical characteri

94 pseudoaneurysm at juxtarenal location with a fistula between the anterior wall of the pseudoaneurysm

95 A fistula between the bulbous urethra and the scrotum was

96 sh, abdominal hernia, recurrence, infection, fistula, bioprosthesis, biocompatible materials, absorba

97 en compared with those with an arteriovenous fistula, but the role of vascular access (VA) type in th

98 erse events such as leaks, perforations, and fistulas, but newer indications such as anchoring of sel

99 ts were identified; all related to obstetric fistula care totalling US$438 million (2006-13).

100 First intervention for pancreatic fistula: catheter drainage or relaparotomy.

101 a patient with dural carotid-cavernous sinus fistula (CCF), which was complicated by increased intra-

102 incontinence, and pregnancy after successful fistula closure in Guinea, and describe the delivery-ass

103 ted outcomes, and pregnancy after successful fistula closure.

104 appearance of healing perianal fistulas and fistula complications is described.

105 lly did not report variables associated with fistula complications, patient comorbidities, vessel cha

106 of collections >2 cm of the treated perianal fistulas confirmed by masked central MRI).

107 unt, with no increase in abscess or draining-fistula counts, at week 12.

108 incidence of clinically relevant pancreatic fistula (CR-POPF) compared with OPD.

109 uced rates of clinically relevant pancreatic fistula (CR-POPF)-the most common and morbid complicatio

110 on after PD - clinically relevant pancreatic fistula (CR-POPF).

111 ciated with a 21% increase in the odds of AV fistula creation or graft placement during that period (

112 ciations between mean visit frequency and AV fistula creation or graft placement in the first 90 days

113 t 90 days of hemodialysis undergo earlier AV fistula creation or graft placement.

114 diocephalic or brachiocephalic arteriovenous fistula creation were randomly assigned (1:1; in blocks

115 ients with lateral sinus dural arteriovenous fistulas (DAVFs).

116 sets with instillation of contrast into the fistula delineates the tract and its components.

117 A ureteric-vaginal fistula developed 2 weeks after uterus procurement.

118 In our case, we believe that the fistula developed iatrogenically during stone excision o

119 Grade 3 fistula developed in 13 (6%) versus one (<1%).

120 is noninferior to OPD in terms of pancreatic fistula development and other major postoperative outcom

121 age renal disease who are not candidates for fistula, dialysis access grafts are the best option for

122 ed in AVF; Akt1 knockout mice showed reduced fistula diameter and wall thickness.

123 esophageal fistula and 1 esophagopericardial fistula) died.

124 ve cases of spontaneous cholecysto-cutaneous fistula draining through an old surgical scar have been

125 rrected esophageal atresia/tracheaesophageal fistula (EA/TEF).

126 r, the mechanism of venous remodeling in the fistula environment is not well understood.

127 0 [IQR, $129764-$173712]), tracheoesophageal fistula/esophageal atresia (WIQR, $39206; median, $10525

128 No region achieved the 50% Fistula First Breakthrough Initiative (now known as Fist

129 First Breakthrough Initiative (now known as Fistula First Catheter Last) target for incident AVF acc

130 s recommendations promote arteriovenous (AV) fistulas first; however, it may not be the best approach

131 The primary outcome was recurrence of fistula following discharge from repair hospital in all

132 This analysis of pancreatic fistulas following pancreatoduodenectomy demonstrates co

133 rted outcomes and clinical outcomes, such as fistula formation and infection, were inconsistently rep

134 Age and Veau Class were associated with fistula formation in a univariate analysis.

135 t in delayed wound healing, wound breakdown, fistula formation, and compromised tissue reconstruction

136 frequency and severity of pharyngocutaneous fistula formation.

137 d increased risk of postoperative pancreatic fistula formation.

138 inal study in women discharged with a closed fistula from three repair hospitals supported by Engende

139 Despite the name AEF, fistulas functionally act 1 way, esophageal to atrial, w

140 e, chest pain, diverticulitis, enterovesical fistula, gastroenteritis, viral gastroenteritis, herpes

141 PF (International Study Group on Pancreatic Fistula Grade B or C) and hospital-related inpatient cos

142 and International Study Group on Pancreatic Fistula grade B/C postoperative pancreatic fistula (POPF

143 ndpoints were clinically relevant pancreatic fistula (grade B/C), mortality, morbidity, and hospital

144 Clinically relevant pancreatic fistula (grade B/C: drain 11.9%, no-drain 5.7%; P = 0.03

145 The fistula group had the lowest mortality over 58 months (h

146 At week twelve, 3 of 9 individual fistulas had healed in group 1 (33.3%), 6 of 7 had heale

147 At week six, 4 of 9 individual fistulas had healed in group 1 (44.4%), 6 of 7 had heale

148 pact on major outcomes, including pancreatic fistula, has yet to be adequately compared with open pan

149 The primary outcome, fistula healing, was determined by physical examination

150 lure, high cardiac output from arteriovenous fistula, hypoxic lung diseases, and metabolic derangemen

151 The XEN 45 mu-fistula implant was successfully placed in both eyes and

152 the first to estimate the burden of vaginal fistula in 19 sub-Saharan Africa countries using nationa

153 ment-related grade 3 event (gastrointestinal fistula in a bevacizumab-treated patient), three grade 2

154 t to obtain multiple sequences to depict the fistula in detail is cumbersome and confusing for the cl

155 the benefits of initiating hemodialysis via fistula in patients with end-stage renal disease irrespe

156 The inability to show the fistula in relation to normal anatomical structures in a

157 nt in the combination arm and one intestinal fistula in the bevacizumab only arm.

158 and point prevalence of symptoms of vaginal fistula in this region using national household surveys

159 in the evaluation of urethral strictures and fistulas in case of 'watering can penis'.

160 Complex perianal fistulas in Crohn's disease are challenging to treat.

161 BACKGROUND & AIMS: Therapies for perianal fistulas in patients with Crohn's disease are often inef

162 tive and safe treatment for complex perianal fistulas in patients with Crohn's disease who did not re

163 01 for treatment-refractory complex perianal fistulas in patients with Crohn's disease.

164 rience with MDCT fistulography in evaluating fistula-in-ano, demonstrates various components of fistu

165 Fistula-in-ano, or perianal fistula, is a challenging cl

166 Female genital fistula is a devastating maternal complication of delive

167 Localization of a cerebrospinal fluid [CSF] fistula is a diagnostic challenge.

168 Postoperative pancreatic fistula is a major contributor to complications and deat

169 Postoperative pancreatic fistula is a potentially life-threatening complication a

170 l problems, spontaneous cholecysto-cutaneous fistula is a rare complication of cholelithiasis in pres

171 Gastropericardial fistula is a rare life-threatening condition, being repo

172 Vaginal fistula is a serious medical disorder characterised by a

173 Dural arteriovenous fistula is a very rare cause of myelitis that can only b

174 adder catheterisation after repair of simple fistula is non-inferior to 14 day catheterisation and co

175 Native arteriovenous fistula is one of the important routes for hemodialysis

176 Although vaginal fistula is relatively rare, it is still too common in su

177 Fistula-in-ano, or perianal fistula, is a challenging clinical condition for both di

178 MDCTF demonstrates the type of fistula, its extent, whether it is simple or complex, an

179 f grade 3 or higher postoperative pancreatic fistula, leak, or abscess was significantly lower among

180 nically significant postoperative pancreatic fistula, leak, or abscess.

181 ments, patients enrolled in the Hemodialysis Fistula Maturation Study underwent up to five preoperati

182 In human AVF and a mouse aortocaval fistula model, Eph-B4 protein expression increased in th

183 2%) or because of intra-abdominal-abscess or fistula (n = 93, 16%).

184 or an esophagopericardial or atrioesophageal fistula (n=2) occurred 15 to 28 days (19+/-6 days) after

185 rdiac, paediatric, reconstructive, obstetric fistula, neurosurgery, burn, general surgery, obstetric

186 rdiac, paediatric, reconstructive, obstetric fistula, neurosurgery, urology, ENT, craniofacial, burn,

187 months follow-up, spontaneous closure of the fistula occurred.

188 73 recurrent fistulas occurred, corresponding to a cumulative inciden

189 or higher (8% vs. 1%), and gastrointestinal fistulas of grade 3 or higher (3% vs. 0%).

190 ader) or development of a new or re-draining fistula or abscess, before or at week 76.

191 ergo surgery to create an arteriovenous (AV) fistula or place an AV graft.

192 ality of programmed VA (PVA), (arteriovenous fistula or PTFE graft) and nonprogrammed VA (UPVA) (tunn

193 depending upon the presence of any remaining fistulas or strictures involving the urethra.

194 scular access choices: maintain CVC, attempt fistula, or attempt graft.

195 ique used in the surgery that play a role on fistula outcomes after primary palatoplasty, particularl

196 ifferences could play a part in palatoplasty fistula outcomes between these three populations.

197 factors, surgical decision-making influences fistula outcomes.

198 analysis, BE was associated with EA without fistula (P = 0.03), previous multiple antireflux surgery

199 enosis in fistulas (P = .047) and autogenous fistulas (P = .04).

200 (P < .001), as was cephalic arch stenosis in fistulas (P = .047) and autogenous fistulas (P = .04).

201 r revision of mesh slings (owing to erosion, fistula, pain, or retention).

202 passage of urine to the scrotum through the fistula, painless scrotal swelling develops, which disap

203 ssociated with a 56% reduction in pancreatic fistula/pancreatic leak/abscess (PF/PL/A) (21.9% to 9.2%

204 The primary endpoint was arteriovenous fistula patency at 3 months.

205 signaling with Ephrin-B2/Fc showed improved fistula patency with less wall thickness.

206 aesthesia improved medium-term arteriovenous fistula patency.

207 n of pasireotide for reduction of pancreatic fistula (PF).

208 h a fistula placed first, a catheter after a fistula placed first failed, or a catheter placed first

209 Of 21,436 patients with a fistula placed first, 9794 initiated hemodialysis with t

210 s in patients initiating hemodialysis with a fistula placed first, a catheter after a fistula placed

211 hier patients are simply more likely to have fistulas placed is unknown.

212 ng hemodialysis with a catheter after failed fistula placement also had significantly lower mortality

213 However, disparities in fistula placement raise the possibility that patient fac

214 Thus, patient factors affecting fistula placement, even when patients are hemodialyzed w

215 s patients, because likelihood of successful fistula placement, procedure-related and subsequent cost

216 dent of factors that drive health access for fistula placement, such as medical insurance status and

217 tiated dialysis with a catheter after failed fistula placement.

218 lude carotid body ablation and arteriovenous fistula placement.

219 ement of mesenchymal stem cell-coated matrix fistula plugs in 12 patients with chronic perianal fistu

220 higher frequency of postoperative pancreatic fistula (POPF) (48.1% vs 27.7%, P = 0.012) and higher se

221 nically significant postoperative pancreatic fistula (POPF) and to evaluate the cost-effectiveness of

222 Postoperative pancreatic fistula (POPF) represents the most significant complicat

223 c Fistula grade B/C postoperative pancreatic fistula (POPF).

224 Postoperative pancreatic fistulas (POPFs), postpancreatectomy hemorrhage (PPH), a

225 sociation between Veau Class and the odds of fistula presentation (Class III or IV vs I or II, OR 5.6

226 regression was used to analyse predictors of fistula presentation among the three cohorts.

227 his retrospective study compared the odds of fistula presentation among three cohorts whose palates w

228 Age, fistula presentation, and Veau Class were compared betwe

229 act of teres ligament covering on pancreatic fistula rate after distal pancreatectomy (DP).

230 r in terms of clinically relevant pancreatic fistula rate and fistula-associated complications.

231 This study investigates the fistula rate in patients from two cohorts in rural China

232 Although the overall fistula rate is not reduced by the coverage procedure, i

233 linically significant (grade B/C) pancreatic fistula rate of 6.9%, and a median length of stay of 9 d

234 The pancreatic fistula rate was significantly lower in the PG group tha

235 The biliary fistula rate was significantly lower in the PG group tha

236 h lower postoperative pancreatic and biliary fistula rates.

237 modialysis are advised to have arteriovenous fistulas rather than catheters because of significantly

238 In patients with Crohn's disease, perianal fistulas recur frequently, causing substantial morbidity

239 Two (5.1%) enteric fistulas recurred and were treated conservatively result

240 incidence proportion, and incidence ratio of fistula recurrence, associated outcomes, and pregnancy a

241 t to analyse the incidence and proportion of fistula recurrence, residual urinary incontinence, and p

242 were 12 stillbirths, seven delivery-related fistula recurrences, and one maternal death.

243 inferior to 14 days in terms of incidence of fistula repair breakdown in women with simple fistula.

244 The primary outcome was fistula repair breakdown, on the basis of dye test resul

245 health outcomes were frequent in women after fistula repair in Guinea.

246 bladder catheterisation after female genital fistula repair varies widely.

247 Fistula repair was not associated with any serious adver

248 eeded to safeguard the health of women after fistula repair.

249 064 and 0.451 times the odds of developing a fistula, respectively, compared with ReSurge patients (p

250 No fistulas resulted in surgical emergencies, sepsis, or de

251 Fistula risk did not differ between cohorts (median FRS:

252 The validated Fistula Risk Score (FRS) intraoperatively predicts the o

253 PF was determined intraoperatively using the Fistula Risk Score (FRS); drains were omitted in negligi

254 for CR-POPF development included increasing Fistula Risk Score (odds ratio 1.49 per point, P < 0.000

255 was assessed using the previously validated Fistula Risk Score, and pancreatic fistulas were stratif

256 The fistula risk was 35.4% in ReSurge patients, 12.8% for pa

257 iew aimed to summarize current literature on fistula risks, including rates of complications, to assi

258 o assess results of surgery for rectovaginal fistula (RVF) and prognostic factors for success.

259 ion injury and in failed human arteriovenous fistula samples after occlusion by dedifferentiated neoi

260 As a rare pathology, urethroscrotal fistula should be considered in men with a history of ur

261 ally and radiologically, dural arteriovenous fistulas should be kept in mind in the etiopathogenesis.

262 culosis, presence of complications (abscess, fistula, stricture, or perforation), and severity of the

263 diabetes, reflecting the effect of lower AV fistula success rates and lower life expectancy.

264 Concomitant procedures included fistula takedown (n = 24) or removal of infected previou

265 e abdominal wall reconstruction with enteric fistula takedown is feasible at the cost of considerable

266 s have higher post-operative odds of palatal fistula than do children treated by local physicians.

267 e perianal edema and is less likely to cause fistulas than in immunocompetent patients.

268 patients were eligible if they had a simple fistula that was closed after surgery and remained close

269 y be of value in the early identification of fistulas that are unlikely to develop optimally.

270 ation for participating centres and perianal fistula to receive laparoscopic ileocaecal resection or

271 d left atrial perforation was oversewn and a fistula to the right main bronchus was closed by means o

272 a plugs in 12 patients with chronic perianal fistulas to be safe and lead to clinical healing and rad

273 ive open cholecystectomy and excision of the fistula tract.

274 he size and distribution of abscesses and/or fistula tracts, the extent of perianal edema, and the li

275 ydroceles, breast mass, neck mass, obstetric fistula, undescended testes, hypospadias, hydrocephalus,

276 celes, breast masses, neck masses, obstetric fistulas, undescended testes, hypospadias, hydrocephalus

277 ous fistula (AVF) maturation prevent optimal fistula use for hemodialysis; however, the mechanism of

278 k of mortality associated with arteriovenous fistula use in hemodialysis patients is due to the avoid

279 Arteriovenous fistula use increased only minimally, from 12.2% in 2006

280 Urethroscrotal fistula (USF) is an abnormal communication between the u

281 Arteriovenous fistula utilization at initial hemodialysis was lower am

282 , Eph-B4 protein expression increased in the fistula vein; expression of the arterial determinant Eph

283 istration of inactive Eph-B4-Y774F increased fistula wall thickness.

284 The overall incidence of grade B/C fistula was 21%, and the in-hospital mortality was 6%.

285 We excluded women if their fistula was not simple or was radiation-induced, associa

286 The fistula was occluded with embolization and the patient s

287 External opening of the fistula was overlying an old surgical scar.

288 The fistula was surgically repaired.

289 , neck mass, undescended testes, and vaginal fistula) was created.

290 Juglans regia, Moringa oleifera, and Cassia fistula) was investigated.

291 se and treatment-refractory complex perianal fistulas, we found Cx601 to be safe and effective in clo

292 nectomy, 309 patients with severe pancreatic fistula were included.

293 atment-refractory, draining complex perianal fistulas were randomly assigned (1:1) using a pre-establ

294 n waitlisted, individuals with arteriovenous fistulas were significantly less likely than individuals

295 validated Fistula Risk Score, and pancreatic fistulas were stratified by International Study Group cr

296 form of hemobilia caused by arterio-biliary fistula which developed incidentally after liver biopsy

297 As a result, a fistula with its opening in the fundus of the gall bladd

298 r management of women after repair of simple fistula with no evidence of a significantly increased ri

299 e prevalence and point prevalence of vaginal fistula with use of Bayesian hierarchical meta-analysis.

300 irs remain an attractive surgical option for fistulas with unfavorable local conditions such as those